Daratumumab Hyaluronidase-fihj

daratumumab; hyaluronidase-fihj · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Daratumumab Hyaluronidase-fihj, covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma [Phase 1]